$阿卡迪亚(ACAD)$

1. 3月份的重大事件：Topline results from ADVANCE-2 in NSS in 1Q24;

2.Rett Syndrome新药销售额预计持续超预期。后续留意下基因治疗Neurogene的Interim Phase 1/2 clinical data 4Q:24